Jacob New
Hematology & Oncology · la Jolla, CANPI 1740800325
Payments from drug & device makers
Across 89 payments — averaging $27.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$393
- Gilead$375
- AbbVie$175
- Takeda Pharmaceuticals U.S.A., Inc.$147
- Eisai Inc.$139
- Merck$131
- plus $1K from 24 others
What the payments were for
- Food & beverage$2,488100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 5 | $393 |
| Gilead(2 entities) | 14 | $375 |
| AbbVie | 7 | $175 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $147 |
| Eisai Inc. | 6 | $139 |
| Merck | 7 | $131 |
| Amgen | 2 | $126 |
| Pharmaessentia USA Corporation | 3 | $98 |
| Pfizer | 4 | $97 |
| AstraZeneca | 3 | $71 |
| GSK | 3 | $65 |
| Deciphera Pharmaceuticals Inc. | 2 | $57 |
| Stemline Therapeutics Inc. | 2 | $55 |
| Beigene USA, Inc. | 2 | $53 |
| Seagen Inc. | 2 | $51 |
| Puma Biotechnology, Inc. | 2 | $49 |
| Array Biopharma Inc | 2 | $46 |
| Johnson & Johnson | 2 | $46 |
| Novartis | 2 | $44 |
| Bayer | 1 | $35 |
| Daiichi Sankyo Inc. | 2 | $32 |
| CSL Behring | 2 | $31 |
| Blueprint Medicines Corporation | 1 | $29 |
| ADC Therapeutics America, Inc. | 1 | $29 |
| Astellas Pharma US Inc | 1 | $24 |
| Incyte Corporation | 1 | $22 |
| Tersera Therapeutics LLC | 1 | $20 |
| Tempus AI, Inc | 1 | $20 |
| Regeneron Healthcare Solutions, Inc. | 1 | $15 |
| Sobi, Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,488 in reported general payments places this provider in the 35th percentile of 1,363 hematology & oncology providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 14 | $143 |
Paid to pharmacies, not to this prescriber.
Other hematology & oncology in la Jolla
- Dimitrios Tzachanisla Jolla$4M
- Alain AlgaziSan Francisco$119.2M
- David BerzLos Angeles$43.3M
- Jonathan GoldmanSanta Monica$35.7M
- Omid HamidSanta Monica$23.7M
- Nicholas McAndrewLos Angeles$22.9M
- Aditya BardiaSanta Monica$22.1M
- Joseph TuscanoSacramento$20.4M
- Zev WainbergSanta Monica$19.3M
- Caitlin CostelloSan Diego$16.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.